瀛晟科學:二零二三年年報
Winshine Science Signs MoU to Cooperate in New Medical Aesthetics Market
Winshine Science (HKG:0209) has signed a memorandum of understanding with an independent third party to strategically cooperate in the medical field, a Tuesday filing on the Hong Kong bourse stated. U
Yingsheng Science (00209.HK) plans to jointly develop business in the new medical aesthetic market with strategic partners
Yingsheng Science (00209.HK) announced that on April 16, 2024, the company signed a memorandum of understanding with an independent third party (strategic partner) on strategic cooperation in the medical field. According to the memorandum of understanding, the two sides plan to establish a long-term strategic partnership to jointly develop business in the new medical aesthetic market, including entering the API market, with a view to achieving mutual benefit and common progress in technology in the medical field to meet the broader needs of human health.
Yingsheng Science (00209) signed a memorandum of understanding with an independent third party on strategic cooperation in the medical field
Yingsheng Science (00209) issued an announcement. On April 16, 2024, the company and an independent third party (battle...
WINSHINE SCI To Carry Out 1-for-5 Reverse Stock Split On May 24th, 2024
April 13th - $WINSHINE SCI(00209.HK)$ is about to implement a 1-for-5 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from May 24th, 2024.$WINSHINE SCI(00209.HK)
Yingsheng Science (00209.HK) plans to consolidate shares according to the “5 and 1” basis
Gelonghui, April 12, 丨 Yingsheng Science (00209.HK) announced that the board of directors proposed a share consolidation based on merging issued and unissued shares with a face value of HK$0.01 per five (5) shares into one (1) share with a face value of HK$0.05 per share. The board recommended that share capital reduction and share segmentation be implemented immediately after the share merger comes into effect. Based on this: (i) the company's issued share capital will be reduced by cancelling the paid-up share capital (up to the limit of HK$0.04 per share issued at the time), so that the face value of each issued consolidated share will be reduced from HK$0.05 to HK$0.01; and (
Ying Sheng Science (00209.HK): Li Zhonghai was appointed as Executive Director
Gelonghui, April 12, 丨 Yingsheng Science (00209.HK) announced that Li Zhonghai has been appointed as the company's executive director, effective April 12, 2024.
Yingsheng Science (00209) announced annual results. Shareholders' losses amounted to HK$28.65 million, a year-on-year profit to loss
Zhitong Finance App News, Yingsheng Science (00209) announced the full year results of 2023, with revenue of HK$523 million, a year-on-year decrease of 38.3 million...
WINSHINE SCI: ANNOUNCEMENT OF FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Winshine Science Forecasts Slimmer Loss in 2023
Winshine Science (HKG:0209) expects to log a loss of HK$30 million for the year ended Dec. 31, 2023, versus HK$850 million in 2022, according to a company filing with the Hong Kong Stock Exchange on T
Yingsheng Science (00209.HK) plans to hold a board meeting on March 28 to consider and approve the annual results
Gelonghui, March 14, 丨 Yingsheng Science (00209.HK) announced that the company's board of directors meeting will be held on March 28, 2024 (Thursday) to approve (among other things) the audited annual results of the company and its subsidiaries for the year ended 31 December 2023, and to recommend the declaration of a final dividend (if any).
Yingsheng Science (00209) is forecasting an annual loss of about HK$30 million
Yingsheng Science (00209) issued an announcement. The company expects revenue for the year ended December 31, 2023 to be approximately...
Winshine Science Raises HK$6.5 Million From Share Subscription Deal
Winshine Science (HKG:0209) raised net proceeds worth HK$6.5 million after completing a share subscription agreement to fund its general working capital. The toy and beverage maker issued 101,964,566
Yingsheng Science (00209.HK) completed allotment of 102 million shares
Gelonghui January 15 | Yingsheng Science (00209.HK) announced that the prerequisites for completion have been met and completed on January 15, 2024. 102 million subscribed shares (equivalent to approximately 16.6% of the total number of shares of the company after the issuance and allocation of subscribed shares) have been allocated and issued to the subscribers at the subscription price of HK$0.066 per subscribed share.
Yingsheng Science (00209.HK) received an OTC share increase of 102 million shares worth HK$6.7297 million from Hurray Talent Investment Development Limited
On January 3, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on January 3, Hurray Talent Investment Development Limited increased its OTC share holdings of $Yingsheng Science (00209.HK) by $102 million at an average price of HK$0.066 per share on January 2, worth about HK$6.7297 million. After the increase in holdings, Hurray Talent Investment Development Limited's latest shareholding number was 102 million shares, with a good position ratio of 0
Ying Sheng Science (00209.HK): Liao Wenjian Resigns as Executive Director
On December 28, Ge Longhui | Yingsheng Science (00209.HK) issued an announcement. Liao Wenjian resigned as the company's executive director, effective December 28, 2023, because he wanted to invest more time in other personal matters.
WINSHINE SCI: SUPPLEMENTAL ANNOUNCEMENT
WINSHINE SCI: INTERIM REPORT 2023
WINSHINE SCI: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
Winshine Science to Swing to Loss in H1
Winshine Science (HKG:0209) warned it will incur a loss of approximately HK$20 million for the first half, reversing a profit of about HK$13 million a year earlier due to a decline in purchase orders
No Data